tiprankstipranks

David Joshua Bartch Insider Profile

4 Followers
David Joshua Bartch, Chief Executive Officer, Ten Percent Owner at Mydecine Innovations Group, holds 6.83M shares in Mydecine Innovations Group (Ticker: TSE:NVRS).
tipranks
David Joshua Bartch

David Joshua Bartch
Mydecine Innovations Group (NVRS)
Chief Executive Officer, Ten Percent Owner

Ranked #53,387 out of 107,104 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

0.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

C$8M
100.00%
A breakdown of David Joshua Bartch's holdings

Insider Roles

Mydecine Innovations Group
(NVRS)
Chief Executive Officer, Ten Percent Owner
Roles that David Joshua Bartch holds in companies

Most Profitable Insider Trade

Stock:
Mydecine Innovations Group
(NVRS)
Rating:Informative Sell
Date:May 25, 2022 - May 25, 2023
Return:0.00%
The most profitable trade made by David Joshua Bartch

David Joshua Bartch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mydecine Innovations Group
Mar 10, 2026
Chief Executive Officer, Ten Percent Owner
Uninformative Sell
1.31M
C$8.26M
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 10, 2026
Uninformative Sell
C$1.31M
6,797,900
C$0.19
May 25, 2022
Informative Sell
C$0.00
4,000,000
C$0.00
0.00%
May 25, 2022
Informative Sell
C$0.00
2,529,956
C$0.00
0.00%
List of latest transactions for each holding click on a transaction to see David Joshua Bartch's performance on stock

David Joshua Bartch insider profile FAQ

What is the percentage of profitable transactions made by David Joshua Bartch?
The percentage of profitable transactions made by David Joshua Bartch is 0%.
    What is the average return per transaction made by David Joshua Bartch?
    The average return per transaction made by David Joshua Bartch is 0.00%.
      What stocks does David Joshua Bartch hold?
      David Joshua Bartch holds: TSE:NVRS stocks.
        What was David Joshua Bartch’s latest transaction?
        David Joshua Bartch latest transaction was an Uninformative Sell of C$1.31M.
          What was David Joshua Bartch's most profitable transaction?
          David Joshua Bartch’s most profitable transaction was an Informative Sell of TSE:NVRS stock on May 25, 2022. The return on the trade was 0.00%.
            What is David Joshua Bartch's role in Mydecine Innovations Group?
            David Joshua Bartch's role in Mydecine Innovations Group is Chief Executive Officer, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.